In a full digitized future, biopharmaceutical companies should be able to process and analyze disparate medical and RWE data to crystallize care journeys across any therapeutic areas- in minutes. However, [...]
Whether you’re sizing the addressable market for a specific disease area or refining your pricing assumptions for a potential new asset, you need analytics that can give you the most precise inputs, fast. [...]
This month, Clarify Health hosted a webinar with Reuters Events Pharma to discuss decoding patient journeys for commercial impact. It included an all-star panel of speakers from Clarify, Eli Lilly, [...]
Ten experts, including our CEO, Jean Drouin, MD, contributed to the November issue of PM360, “Data Overload—The Best Ways to Manage and Interpret Data.” Experts from across the life sciences [...]
The revenue performance of a pharmaceutical drug at launch sets the stage for its commercial future. However, approximately two-thirds of new drugs fall short of first-year sales expectations. In this [...]